The Closed System Drug Transfer Device Market is expanding across major healthcare regions as hospitals and oncology centers increasingly prioritize the safe handling of hazardous medications. The market is supported by rising cancer treatment volumes, regulatory requirements, and growing awareness of occupational exposure risks.

North America is a leading regional market, supported by advanced healthcare infrastructure, established oncology services, and strong adoption of workplace safety technologies. Market Research Future estimates that North America accounted for approximately 46% of the global market in 2025.

Europe also represents a significant market due to healthcare safety regulations and increasing attention to hazardous-drug handling. Hospitals and specialized healthcare facilities are adopting closed transfer technologies to strengthen workplace protection and improve medication-handling procedures.

Asia-Pacific is expected to be one of the fastest-growing regions. The market is projected to expand at approximately 16.0% CAGR through 2035, supported by increasing oncology infrastructure, healthcare expenditure, and adoption of safe drug-handling practices.

South America and the Middle East and Africa are also expected to provide future opportunities as healthcare infrastructure develops and cancer-treatment capacity expands.

Country-level markets are developing alongside national healthcare initiatives. For example, Market Research Future projects India's market to increase from USD 52.88 million in 2025 to USD 139.33 million by 2035.

Regional healthcare investments and increasing regulatory awareness are expected to support continued market expansion.